Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.72
+0.05001.87%
Volume:315.18K
Turnover:850.82K
Market Cap:530.40M
PE:-10.73
High:2.74
Open:2.64
Low:2.64
Close:2.67
52wk High:3.11
52wk Low:1.12
Shares:195.00M
Float Shares:163.00M
Volume Ratio:0.46
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2535
EPS(LYR):-0.2325
ROE:-25.96%
ROA:-23.46%
PB:2.53
PE(LYR):-11.70

Loading ...

May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Major Issues Report

8-K - Current report